The healthcare industry as a whole is undergoing a period of dramatic change, with advocates on all sides reassessing policies and best practices in numerous areas of patient care. At the same time, the long term healthcare (LTC) sector is experiencing rapid growth as more and more Americans enter into assisted living and skilled nursing facilities. While working to provide superior resident care, communities are tasked with keeping up with ever-changing, overarching healthcare regulations and addressing how new laws will impact the unique LTC environment.
In 2014, the Drug Enforcement Administration (DEA) enacted two major regulatory changes which have already impacted the LTC industry and will be a key focus in 2015. The DEA’s rulings on the disposal of pharmaceutical controlled substances and the reclassification of hydrocodone combination products (HCPs) from Schedule III to Schedule II mean new procedures and practices for all involved, including physicians, facilities, pharmacies and other partners in care.